On July 31, the 26th International AIDS Conference (AIDS 2026) concluded successfully in Rio de Janeiro, Brazil. As one of the world’s leading international platforms for academic exchange in HIV prevention and control, the conference brought together scientists, public health experts, clinicians, community representatives and policymakers from around the world to discuss the latest advances and future directions in the global HIV response.

        During the conference, LivzonDx presented its innovative products and practical achievements in HIV diagnostics. The company also held in-depth discussions with experts, researchers and industry partners from different countries and regions on the application and future development of HIV testing technologies.

01  China Satellite Symposium: Four Decades of Progress, Reflection and Outlook

        During the conference, the satellite symposium themed “Four Decades of China’s Response to HIV/AIDS: Retrospect and Prospect” was successfully held. The event was jointly organized by the Chinese Association of STD and AIDS Prevention and Control, the Chinese Preventive Medicine Association, and the National Center for AIDS/STD Control and Prevention of the Chinese Center for Disease Control and Prevention.

        Experts from UNAIDS, the World Health Organization, and disease control and medical institutions in China were invited to participate. Speakers shared China’s progress, experience and achievements in HIV/AIDS prevention and control over the past four decades, offering diverse perspectives for advancing future HIV prevention and control efforts.

02  Innovation-Driven HIV Diagnostic Solutions Supporting Global Public Health

        As one of the most influential international academic events in the field of HIV/AIDS prevention and control, AIDS 2026 brought together leading researchers, public health experts and industry leaders from around the world. On this global stage, LivzonDx presented its comprehensive portfolio of innovative HIV diagnostic products, demonstrating the technological advances and practical achievements of China’s in vitro diagnostics industry in the fight against HIV/AIDS.

        From precision breakthroughs in viral load testing, to progress in international registration and certification, and further to localized operations in global markets, LivzonDx attracted extensive attention and in-depth engagement from health ministry officials, laboratory directors and clinical experts worldwide. Its booth served as an important window into China’s growing capabilities in HIV diagnostics.

HIV Viral Load Testing: Strength Behind China’s Leading Domestic Brand

        Widely regarded as the gold standard for monitoring HIV treatment, viral load testing directly reflects the effectiveness of antiretroviral therapy and is a key indicator for adjusting treatment strategies and evaluating treatment outcomes.

        LivzonDx has been deeply engaged in HIV viral load testing for many years. Backed by strong product quality and stable performance, its domestic market share exceeds 35%, making it the leading Chinese brand and a mainstream choice for disease control centers and healthcare institutions at all levels. The product has received support from the Gates Foundation, and WHO prequalification is currently being advanced. In the future, it is expected to enter global public health procurement systems and support HIV prevention and control in more developing countries.

Core Technical Advantages

· Fully automated, high-throughput and high-precision integrated viral load system: the highest domestic market share in China, with high analytical sensitivity and a wide linear range to support the full clinical care pathway.

· The world’s first dual-platform viral load testing solution: designed to meet the diverse throughput requirements of healthcare institutions at different levels, from high-volume testing in major tertiary hospitals to medium-throughput applications in primary laboratories.

· China’s first single-dose lyophilized reagent: helps address the challenges of stringent cold-chain requirements and short open-vial stability associated with conventional liquid reagents. It supports room-temperature transportation and storage and is ready to use, making it especially suitable for primary healthcare facilities and resource-limited settings.

        With stable performance and reliable quality, LivzonDx’s HIV products have received recognition from international peers and have also provided new ideas and practical reference for improving HIV testing capacity and laboratory service systems in different countries and regions.

International Recognition and Global Expansion

        Through years of sustained development, LivzonDx has established a global market network and localized operational capabilities. As the only Chinese HIV viral load testing company to receive support from the Gates Foundation, LivzonDx has gained recognition from a leading international institution for its technological strength and product performance.

        WHO prequalification for the relevant products is being accelerated, while market access planning is already under way in several key countries and regions. Going forward, the company will continue to expand its international presence and provide market development, technical support and services tailored to local needs, helping high-burden regions strengthen their HIV testing capacity.

03  Looking Ahead

        LivzonDx has years of experience in HIV/AIDS testing and consistently prioritizes clinical and public health testing requirements. The company has developed a comprehensive, high-precision testing solution covering the full HIV care pathway—from screening and confirmation to coinfection differentiation and treatment monitoring.

        This complete product portfolio supports a wide range of testing scenarios and addresses the needs of disease control centers, hospitals, primary healthcare institutions and other laboratories at different levels.

Going forward, we will continue to:

· Drive innovation and develop more accurate and convenient HIV diagnostic products.

· Deepen international cooperation and work with global partners to advance HIV diagnostic technologies.

· Improve access so that more people in need can benefit from high-quality diagnostic services.

· Share Chinese experience and solutions and contribute Chinese expertise to the global HIV response.

        Thank you, Rio de Janeiro, and thank you to every partner and colleague who visited our booth.

        We look forward to working alongside HIV prevention and control professionals worldwide and contributing to the goal of ending AIDS as a public health threat by 2030.